Safety and Efficacy of Atezolizumab-Bevacizumab Versus Tyrosin Kinase Inhibitors in Patients With Liver Cirrhosis
Clinical trial NCT07193316 · COMPLETED
Trial details
- NCT number
- NCT07193316
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-27
- Primary completion
- 2024-10-31
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.